Company
Headquarters: Shanghai, China
Employees: 1,308
CEO: Dr. Xiucai Liu
CN¥33.99 Billion
CNY as of July 1, 2025
US$4.75 Billion
| Company | Market Cap (USD) |
|---|---|
| Air Liquide SA | $121.83 B |
| Air Products and Chemicals, Inc. | $64.60 B |
| Shin-Etsu Chemical Co Ltd | $62.74 B |
| BASF SE | $46.38 B |
| Saudi Basic Industries Corp | $44.80 B |
| Company | Market Cap (USD) |
|---|---|
| Linde | $224.62 B |
| BHP | $151.21 B |
| Air Liquide SA | $121.83 B |
| Rio Tinto | $95.24 B |
| The Sherwin-Williams Company | $88.71 B |
Cathay Biotech Inc. engages in the production and sale of bio-based polyamide, bio-based DN5, long chain dibasic acids, and biobutanol. The company is headquartered in Shanghai, China.
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | CN¥3.05 B |
| EBITDA | CN¥693.6 M |
| Gross Profit TTM | CN¥901.0 M |
| Profit Margin | 17.08% |
| Operating Margin | 18.45% |
| Quarterly Revenue Growth | 13.30% |
Cathay Biotech, Inc. has the following listings and related stock indices.
Stock: SSE: 688065 wb_incandescent